Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
US5888535A · kind A · utility
9Cited by
1References
28Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 23, 1996 |
| Grant date | Mar 30, 1999 |
| Priority date | — |
| Expiry date | Dec 23, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions are disclosed utilizing optically pure (-) pantoprazole for the treatment of ulcers in humans while substantially reducing the concomitant liability of adverse effects associated with the racemic mixture of pantoprazole. The optically pure (-) isomer is also useful for the treatment of gastroesophageal reflux. (-) Pantoprazole is an inhibitor of H.sup.+ release and is therefore useful in the treatment of other conditions related to gastric hypersecretion such as Zollinger-Ellison Syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.